This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Amyris Temettü

Temettü kriter kontrolleri 0/6

Amyris şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-7,027.1%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-7,027.1%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Apr 12

Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

Mar 22

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Oct 31

Amyris Cost Breakdown

Oct 07

Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability

Oct 01

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Sep 02

Amyris: In Dire Need For Additional Capital

Aug 22

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Aug 12

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

Aug 08

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: AMRS.Q şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: AMRS.Q şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Amyris Piyasaya Karşı Temettü Getirisi

AMRS.Q temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (AMRS.Q)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.5%
Sektör Ortalaması (Chemicals)	2.0%
Analist tahmini (AMRS.Q) (3 yıla kadar)	n/a

Önemli Temettü: AMRS.Q şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, AMRS.Q şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: AMRS.Q şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: AMRS.Q herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

This company listing is no longer active

Amyris Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Kathy L. Fortmann to Join Amyris, Inc. as Member of the Board of Directors

Amyris, Inc. announced delayed annual 10-K filing

Third Amended Joint Reorganization Plan Filed by Amyris, Inc.

Foris Ventures Provides Information to the Shareholders

Amyris, Inc. Announces Resignation of Elizabeth Dreyer as Chief Accounting Officer and Corporate Controller, Effective as of January 2, 2024

Amyris, Inc. announced delayed 10-Q filing

Nasdaq to Delist the Common Stock of Amyris

Amyris, Inc. Appoints Scott White as A Class II Director

Motion for Joint Administration Filed by Amyris, Inc.

Amyris' Common Stock To Be Delisted from Nasdaq

Amyris, Inc. announced delayed 10-Q filing

Amyris, Inc. Filed for Bankruptcy

Amyris, Inc. Announces Executive Changes

Amyris Receives Deficiency Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement

First quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.75 loss

Price target increased by 9.0% to US$3.40

What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

Full year 2022 earnings: EPS and revenues miss analyst expectations

No longer forecast to breakeven

Price target decreased by 8.2% to US$3.12

Amyris Launches 4U by Tia™ Haircare Line Exclusively At Walmart

Amyris, Inc. announced that it expects to receive $20.000001 million in funding from Foris Ventures, LLC

Amyris, Inc. Announces Executive Changes

No longer forecast to breakeven

No longer forecast to breakeven

Forecast to breakeven in 2024

Amyris, Inc. Provides Financial Guidance for the Fourth Quarter of 2022

Price target decreased to US$9.31

Amyris, Inc. to Report Q3, 2022 Results on Nov 08, 2022

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Amyris, Inc. Launches Two New Consumer Brands

Amyris, Inc. Announces Three of Its Consumer Brands Will Be Included in Sephora's Launch in the United Kingdom

Amyris Cost Breakdown

Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability

Elizabeth Dreyer Joins Amyris, Inc. as Chief Accounting Officer & Corporate Controller, Effective October 11, 2022

CFO & Chief Administration Officer recently sold US$74k worth of stock

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Amyris: In Dire Need For Additional Capital

President recently bought US$69k worth of stock

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Price target decreased to US$10.91

Forecast to breakeven in 2024

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Amyris, Inc. Provides Revenue Guidance for 2022

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

Amyris, Inc. to Report Q2, 2022 Results on Aug 09, 2022

President recently sold US$118k worth of stock

Amyris: Revenues Need To Catch Expenses

Chief Legal Officer & Secretary notifies of intention to sell stock

Amyris, Inc. Announces Executive Changes Effective June 17, 2022

CFO & Chief Administration Officer recently sold US$82k worth of stock

High number of new directors

Amyris, Inc., Annual General Meeting, Jun 10, 2022

Amyris: Elevated Cash Usage Causes Investors To Head For The Exits

Amyris, Inc. to Report Q1, 2022 Results on May 10, 2022

Amryis Update: Building Value One Brick At A Time

Amyris, Inc. (NasdaqGS:AMRS) entered into an Agreement and Plan of Merger and Reorganization to acquire Onda Beauty Inc.

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin